These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3524221)

  • 1. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
    Lerner SA; Schmitt BA; Seligsohn R; Matz GJ
    Am J Med; 1986 Jun; 80(6B):98-104. PubMed ID: 3524221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin.
    Lerner SA; Seligsohn R; Matz GJ
    Am J Med; 1977 Jun; 62(6):919-23. PubMed ID: 868906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside toxicity in infants and children.
    McCracken GH
    Am J Med; 1986 Jun; 80(6B):172-8. PubMed ID: 3524215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity.
    Barza M; Lauermann MW; Tally FP; Gorbach SL
    Antimicrob Agents Chemother; 1980 Apr; 17(4):707-14. PubMed ID: 6994638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.
    Holm SE; Hill B; Löwestad A; Maller R; Vikerfors T
    J Antimicrob Chemother; 1983 Oct; 12(4):393-402. PubMed ID: 6643334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].
    Federspil P; Schindler K; Weich C; Tiesler E; Schätzle W; Ziegler M
    Infection; 1979; 7(2):81-7. PubMed ID: 374277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of aminoglycosides in young and adult rats.
    Provoost AP; Adejuyigbe O; Wolff ED
    Pediatr Res; 1985 Nov; 19(11):1191-6. PubMed ID: 4069829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.
    French MA; Cerra FB; Plaut ME; Schentag JJ
    Antimicrob Agents Chemother; 1981 Jan; 19(1):147-52. PubMed ID: 7247354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside ototoxicity.
    Matz GJ
    Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 'high-dose' amikacin in children.
    Kumor KM; McDonald JM; Lietman PS
    Dev Pharmacol Ther; 1984; 7(6):368-76. PubMed ID: 6518944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    Setiabudy R; Suwento R; Rundjan L; Yasin FH; Louisa M; Dwijayanti A; Simanjuntak E
    Int J Clin Pharmacol Ther; 2013 May; 51(5):401-6. PubMed ID: 23557866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative overview of randomized trials of aminoglycosides.
    Evans DA; Buring J; Mayrent S; Rosner B; Colton T; Hennekens C
    Am J Med; 1986 Jun; 80(6B):39-43. PubMed ID: 3524219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside toxicity in neonates: something to worry about?
    Kent A; Turner MA; Sharland M; Heath PT
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):319-31. PubMed ID: 24455994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
    Gatell JM; San Miguel JG; Zamora L; Araujo V; Bonet M; Bohé M; Jimenez de Anta MT; Farré M; Elena M; Ballesta A; Marin JL
    Antimicrob Agents Chemother; 1983 Jun; 23(6):897-901. PubMed ID: 6614894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity and nephrotoxicity of netilmicin.
    Federspil P
    Infection; 1976; 4(4):211. PubMed ID: 1017880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.